Literature DB >> 15827561

Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians.

Daniele Ghezzi1, Cecilia Marelli, Alessandro Achilli, Stefano Goldwurm, Gianni Pezzoli, Paolo Barone, Maria Teresa Pellecchia, Paolo Stanzione, Livia Brusa, Anna Rita Bentivoglio, Ubaldo Bonuccelli, Lucia Petrozzi, Giovanni Abbruzzese, Roberta Marchese, Pietro Cortelli, Daniela Grimaldi, Paolo Martinelli, Carlo Ferrarese, Barbara Garavaglia, Simonetta Sangiorgi, Valerio Carelli, Antonio Torroni, Alberto Albanese, Massimo Zeviani.   

Abstract

It has been proposed that European mitochondrial DNA (mtDNA) haplogroups J and K, and their shared 10398G single-nucleotide polymorphism (SNP) in the ND3 gene, are protective from Parkinson's disease (PD). We evaluated the distribution of the different mtDNA haplogroups in a large cohort of 620 Italian patients with adult-onset (>50, <65 years of age) idiopathic PD vs two groups of ethnic-matched controls. Neither the frequencies of haplogroup J nor that of 10398G were significantly different. However, the frequency of haplogroup K was significantly lower in PD. Stratification by sex and age indicated that the difference in the distribution of haplogroup K was more prominent in >50 year old males. In spite of the common 10398G SNP, haplogroups J and K belong to widely diverging mitochondrial clades, a consideration that may explain the different results obtained for the two haplogroups in our cohorts. Our study suggests that haplogroup K might confer a lower risk for PD in Italians, corroborating the idea that the mitochondrial oxidative phosphorylation pathway is involved in the susceptibility to idiopathic PD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827561     DOI: 10.1038/sj.ejhg.5201425

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  73 in total

1.  Principal-component analysis for assessment of population stratification in mitochondrial medical genetics.

Authors:  Alessandro Biffi; Christopher D Anderson; Michael A Nalls; Rosanna Rahman; Akshata Sonni; Lynelle Cortellini; Natalia S Rost; Mar Matarin; Dena G Hernandez; Anna Plourde; Paul I W de Bakker; Owen A Ross; Steven M Greenberg; Karen L Furie; James F Meschia; Andrew B Singleton; Richa Saxena; Jonathan Rosand
Journal:  Am J Hum Genet       Date:  2010-05-27       Impact factor: 11.025

2.  Mitochondrial DNA haplogroups and amyotrophic lateral sclerosis.

Authors:  Patrick F Chinnery; Catherine Mowbray; Hannah Elliot; Joanna L Elson; Hannah Nixon; Judith Hartley; Pamela J Shaw
Journal:  Neurogenetics       Date:  2006-11-03       Impact factor: 2.660

Review 3.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

4.  The power to detect disease associations with mitochondrial DNA haplogroups.

Authors:  David C Samuels; Andrew D Carothers; Robin Horton; Patrick F Chinnery
Journal:  Am J Hum Genet       Date:  2006-02-17       Impact factor: 11.025

5.  Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Authors:  David K Simon; Nathan Pankratz; Diane K Kissell; Michael W Pauciulo; Cheryl A Halter; Alice Rudolph; Ronald F Pfeiffer; William C Nichols; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2010-04-01       Impact factor: 2.103

Review 6.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 7.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

8.  Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort.

Authors:  Katarzyna Gaweda-Walerych; Aleksandra Maruszak; Krzysztof Safranow; Monika Bialecka; Gabriela Klodowska-Duda; Krzysztof Czyzewski; Jaroslaw Slawek; Monika Rudzinska; Maria Styczynska; Grzegorz Opala; Marek Drozdzik; Jeffrey A Canter; Maria Barcikowska; Cezary Zekanowski
Journal:  J Neural Transm (Vienna)       Date:  2008-09-23       Impact factor: 3.575

9.  Mitochondrial DNA Haplogroups and Susceptibility to Neuroblastoma.

Authors:  Xiao Chang; Marina Bakay; Yichuan Liu; Joseph Glessner; Komal S Rathi; Cuiping Hou; Huiqi Qu; Zalman Vaksman; Kenny Nguyen; Patrick M A Sleiman; Sharon J Diskin; John M Maris; Hakon Hakonarson
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

10.  Mitochondrial DNA polymorphisms and haplogroups in Parkinson's disease and control individuals with a similar genetic background.

Authors:  Helen Latsoudis; Cleanthe Spanaki; Grigoris Chlouverakis; Andreas Plaitakis
Journal:  J Hum Genet       Date:  2008-02-20       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.